Endoscopic retrograde cholangiopancreatography (ERCP) is the most direct and effective method for the diagnosis and treatment of biliary and pancreatic diseases. Compared with surgery, ERCP has the advantages of minimal trauma, shorter surgery time, fewer complications, and shorter hospital stay. Liver cirrhosis, as the advanced stage of liver disease, has reduced tolerance to surgical stresses, and complications such as hepatic encephalopathy, esophagogastric varices, and coagulation dysfunction may occur during the decompensated stage, which poses a challenge to ERCP, and thus increase the intraoperative risk and postoperative complications. This article reviews and discusses the indications, risk and control management of ERCP in patients with liver cirrhosis.
经内镜逆行胰胆管造影术（ERCP）是胆胰疾病诊治的最直接有效的手段。与外科手术相比，ERCP具有创伤小、手术时间短、并发症少、住院时间短等优点。肝硬化作为肝病的进展阶段，对手术应激的耐受能力减退，且在失代偿期可能存在肝性脑病、食管胃底静脉曲张、凝血功能障碍等并发症，这为ERCP带来了内镜操作的挑战及增加术中、术后并发症的风险。现对肝硬化患者行ERCP术的适应证、风险及管理控制进行综述和探讨。.
Keywords: Complication; Endoscopic retrograde cholangiopancreatography; Liver cirrhosis.